BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 31382038)

  • 1. Targeting Toll-like receptor 4 with CLI-095 (TAK-242) enhances the antimetastatic effect of the estrogen receptor antagonist fulvestrant on non-small cell lung cancer.
    Fan S; Liao Y; Qiu W; Li L; Li D; Cao X; Ai B
    Clin Transl Oncol; 2020 Nov; 22(11):2074-2086. PubMed ID: 32367494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biofilm exopolysaccharides alter sensory-neuron-mediated sickness during lung infection.
    Granton E; Brown L; Defaye M; Moazen P; Almblad H; Randall TE; Rich JD; Geppert A; Abdullah NS; Hassanabad MF; Hiroki CH; Farias R; Nguyen AP; Schubert C; Lou Y; Andonegui G; Iftinca M; Raju D; Vargas MA; Howell PL; Füzesi T; Bains J; Kurrasch D; Harrison JJ; Altier C; Yipp BG
    Cell; 2024 Apr; 187(8):1874-1888.e14. PubMed ID: 38518773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Selected Toll-like Receptors in the Pathogenesis and Advancement of Non-Small-Cell Lung Cancer.
    Smok-Kalwat J; Mertowska P; Mertowski S; Góźdź S; Korona-Głowniak I; Kwaśniewski W; Grywalska E
    J Clin Med; 2024 May; 13(10):. PubMed ID: 38792335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR5 and TLR4 signals synergistically enhance non-small cell lung cancer progression.
    Shin JH; Kim MJ; Kim JY; Kang Y; Kim DH; Jeong SK; Chun E; Lee KY
    Clin Transl Med; 2024 Jan; 14(1):e1547. PubMed ID: 38239075
    [No Abstract]   [Full Text] [Related]  

  • 5. Less is more: the benefits of low suction for digital pleural drainage devices after pulmonary resection.
    Gowing SD; Resende VF; Gilbert S
    J Thorac Dis; 2019 Sep; 11(Suppl 15):S1999-S2001. PubMed ID: 31632809
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation analysis of lung mucosa-colonizing bacteria with clinical features reveals metastasis-associated bacterial community structure in non-small cell lung cancer patients.
    Wang W; Liang X; Kong H; Yang Y; Xia Y; Wang Q; Xia A; Geng J
    Respir Res; 2023 May; 24(1):129. PubMed ID: 37170267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil extracellular traps primed intercellular communication in cancer progression as a promising therapeutic target.
    Shang B; Cui H; Xie R; Wu J; Shi H; Bi X; Feng L; Shou J
    Biomark Res; 2023 Mar; 11(1):24. PubMed ID: 36859358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the role of Toll-like receptors in lung cancer immunity and immunotherapy.
    Hoden B; DeRubeis D; Martinez-Moczygemba M; Ramos KS; Zhang D
    Front Immunol; 2022; 13():1033483. PubMed ID: 36389785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects.
    Boesch M; Horvath L; Baty F; Pircher A; Wolf D; Spahn S; Straussman R; Tilg H; Brutsche MH
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36343977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lung microbiome, peripheral gene expression, and recurrence-free survival after resection of stage II non-small cell lung cancer.
    Peters BA; Pass HI; Burk RD; Xue X; Goparaju C; Sollecito CC; Grassi E; Segal LN; Tsay JJ; Hayes RB; Ahn J
    Genome Med; 2022 Oct; 14(1):121. PubMed ID: 36303210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation and Functional Enrichment Analysis of the Human Host Interaction Network with Common Gram-Negative Respiratory Pathogens Predicts Possible Association with Lung Adenocarcinoma.
    Giannakou LE; Giannopoulos AS; Hatzoglou C; Gourgoulianis KI; Rouka E; Zarogiannis SG
    Pathophysiology; 2021 Jan; 28(1):20-33. PubMed ID: 35366267
    [No Abstract]   [Full Text] [Related]  

  • 12. Alterations of lung microbiota in patients with non-small cell lung cancer.
    Zeng W; Zhao C; Yu M; Chen H; Pan Y; Wang Y; Bao H; Ma H; Ma S
    Bioengineered; 2022 Mar; 13(3):6665-6677. PubMed ID: 35254206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The airway microbiota of non-small cell lung cancer patients and its relationship to tumor stage and EGFR gene mutation.
    Huang DH; He J; Su XF; Wen YN; Zhang SJ; Liu LY; Zhao H; Ye CP; Wu JH; Cai S; Dong H
    Thorac Cancer; 2022 Mar; 13(6):858-869. PubMed ID: 35142041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of LPS-mediated TLR4 activation abrogates gastric adenocarcinoma-associated peritoneal metastasis.
    Sangwan V; Al-Marzouki L; Pal S; Stavrakos V; Alzahrani M; Antonatos D; Nevo Y; Camilleri-Broët S; Rayes R; Bourdeau F; Giannias B; Bertos N; Bailey S; Rousseau S; Cools-Lartigue J; Spicer JD; Ferri L
    Clin Exp Metastasis; 2022 Apr; 39(2):323-333. PubMed ID: 34767138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology of Community-Acquired Pneumonia Requiring Hospital Admission in Adults with and Without Cancers: A Single-Center Retrospective Study in China.
    Wang X; Zhang H; Zhang T; Pan L; Dong K; Yang M; Ma R; Li Y
    Infect Drug Resist; 2020; 13():1607-1617. PubMed ID: 32606812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gram-Negative Pneumonia Augments Non-Small Cell Lung Cancer Metastasis through Host Toll-like Receptor 4 Activation.
    Gowing SD; Chow SC; Cools-Lartigue JJ; Chen CB; Najmeh S; Goodwin-Wilson M; Jiang HY; Bourdeau F; Beauchamp A; Angers I; Giannias B; Spicer JD; Rousseau S; Qureshi ST; Ferri LE
    J Thorac Oncol; 2019 Dec; 14(12):2097-2108. PubMed ID: 31382038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gram-positive pneumonia augments non-small cell lung cancer metastasis via host toll-like receptor 2 activation.
    Gowing SD; Chow SC; Cools-Lartigue JJ; Chen CB; Najmeh S; Jiang HY; Bourdeau F; Beauchamp A; Mancini U; Angers I; Giannias B; Spicer JD; Rousseau S; Qureshi ST; Ferri LE
    Int J Cancer; 2017 Aug; 141(3):561-571. PubMed ID: 28401532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gram negative bacteria increase non-small cell lung cancer metastasis via Toll-like receptor 4 activation and mitogen-activated protein kinase phosphorylation.
    Chow SC; Gowing SD; Cools-Lartigue JJ; Chen CB; Berube J; Yoon HW; Chan CH; Rousseau MC; Bourdeau F; Giannias B; Roussel L; Qureshi ST; Rousseau S; Ferri LE
    Int J Cancer; 2015 Mar; 136(6):1341-50. PubMed ID: 25082668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NADPH oxidase 1-dependent ROS is crucial for TLR4 signaling to promote tumor metastasis of non-small cell lung cancer.
    Liu X; Pei C; Yan S; Liu G; Liu G; Chen W; Cui Y; Liu Y
    Tumour Biol; 2015 Mar; 36(3):1493-502. PubMed ID: 25592377
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.